journal article·2020-07-10Open access

Effect of Daily Intake of a Saffron Infusion on Blood Cholesterol Levels

M. José Bagur, Gonzalo L. Alonso Salinas, Antonia M. Jiménez-Monreal, Gemma Serrano-Heras, Magdalena Martínez-Tomé., Gonzalo L. Alonso

Applied Sciences· Volume 10· Issue 14

Abstract

Saffron (Crocus sativus L.), as well as having notable culinary value, has been traditionally used as a medicinal plant due to its bioactivity. Furthermore, its antioxidant properties have been evaluated, and it may have cardiovascular benefits. Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes a diminution in the daily physical exercise of patients. This sedentary lifestyle may contribute to an increased incidence of dyslipidaemia in this population, and could explain the increased cardiovascular morbidity. The aim of this study was to assess the effect of the intake of a saffron infusion over 96 days on the lipid profile of MS patients. Considering the extraction kinetics of bioactive metabolites, the best way to prepare the infusion was by using ground saffron (PDO “Azafrán de La Mancha”), passed through a 0.5 mm sieve and infused with water at the boiling point (95–100 °C). A total of 35 MS patients took a midafternoon infusion for 96 days; 16 of them completed the treatment. A significant decrease in total blood cholesterol levels from 199.5 to 179.5 mg/dL was observed. Additionally, a significant diminution of triglyceride levels, from 124.0 to 101.0 mg/dL, was observed. In conclusion, the intake of an infusion of 50 mg of “Azafrán de La Mancha” for 96 days had a lipid-lowering effect in patients with MS.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Saffron Plant Research Studies · Hedgehog Signaling Pathway Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cátedra de Química Agrícola, E.T.S.I. Agrónomos y de Montes, Campus Universitario, Universidad de Castilla-La Mancha, 02071 Albacete, Spain

Department of Cardiology, University Alcalá, Hospital Ramon y Cajal, 28034 Madrid, Spain

Department of Food Science, Regional Campus of International Excellence, Campus International de Excelencia Regional “Campus Mare Nostrum”, CIBERobn, ISCIII, Universidad de Murcia, 30100 Murcia, Spain

Unidad de Investigación, Complejo Hospitalario Universitario de Albacete, 02008 Albacete, Spain

References (42)

Show source-provided references
1. Fernández, O., Fernández, V.E., and Guerrero, M. (2011). Esclerosis Múltiple, McGraw-Hill/Interamericana.
2. Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study10.1016/j.jns.2014.02.038 ↗
3. Cholesterol and markers of cholesterol turnover in multiple sclerosis: Relationship with disease outcomes10.1016/j.msard.2015.10.005 ↗
4. Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis10.1016/j.neulet.2015.08.054 ↗
5. Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases10.1016/j.phrs.2014.03.001 ↗
6. An evidence-based systematic review of saffron (Crocus sativus) by the Natural Standard Research Collaboration10.3109/19390211.2011.547666 ↗
7. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease10.1007/s00213-009-1706-1 ↗
8. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration10.1167/iovs.09-4995 ↗
9. Immunomodulatory effects of saffron: A randomized double-blind placebo-controlled clinical trial10.1002/ptr.3484 ↗
10. A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia10.1002/ptr.3294 ↗
11. Effect of saffron on fluoxetine-induced sexual impairment in men: Randomized double-blind placebo-controlled trial10.1007/s00213-012-2729-6 ↗
12. Effect of Crocus sativus L. (saffron) on coagulation and anticoagulation systems in healthy volunteers10.1002/ptr.5021 ↗
13. Saffron for treatment of fluoxetine-induced sexual dysfunction in women: Randomized double-blind placebo-controlled study10.1002/hup.2282 ↗
14. Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: A preliminary report
15. The ocular hypotensive effect of saffron extract in primary open angle glaucoma: A pilot study
16. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients10.1016/j.jad.2013.11.003 ↗
17. Cardiovascular effects of saffron: An evidence-based review
18. Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS10.1021/jf052297w ↗
19. Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails10.1016/j.ejphar.2006.09.071 ↗
20. Crocetin reduces the oxidative stress induced reactive oxygen species in the stroke-prone spontaneously hypertensive rats (SHRSPs) brain10.3164/jcbn.11-01 ↗
21. Crocin attenuate Tumor Necrosis Factor-alpha (TNF-α) and interleukin-6 (IL-6) in streptozotocin-induced diabetic rat aorta10.1016/j.cyto.2016.08.002 ↗
22. Potential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in rats10.1007/s12010-009-8740-7 ↗
23. Medizinische Empirie und moderne Arzneimittelforschung
24. Trans-sodium crocetinate for treating hypoxia/ischemia10.1517/13543784.17.6.917 ↗
25. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits10.1016/j.bcp.2005.07.034 ↗
26. Mechanism of hypolidemic effect of crocin in rats: Crocin inhibits pancreatic lipase10.1016/j.ejphar.2006.05.038 ↗
27. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats10.1002/ptr.4836 ↗
28. Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats10.1002/ptr.4784 ↗
29. Role of saffron (Crocus sativus L.) and honey syrup on aluminum-induced hepatotoxicity
30. Determination of saffron quality by high-performance liquid chromatography10.1021/jf5019356 ↗
31. ISO 3632 (2011). Saffron (Crocus Sativus, L.). Part 1 (Specification) and Part 2 (Test Methods), International Organization for Standardization.
32. Clinical Applications of Saffron (Crocus sativus) and Its Constituents: A Review10.1055/s-0034-1375681 ↗
33. Crocus sativus L.: A comprehensive review10.4103/0973-7847.70919 ↗
34. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers10.1016/j.phymed.2008.06.003 ↗
35. Quantification of saffron (Crocus sativus L.) metabolites crocins, picrocrocin and safranal for quality determination of the spice grown under different environmental Moroccan conditions10.1016/j.scienta.2009.02.017 ↗
36. Effects of mild temperature conditions during dehydration procedures on saffron quality parameters10.1002/jsfa.3877 ↗
37. Comparative evaluation of an ISO 3632 method and an HPLC-DAD method for safranal quantity determination in saffron10.1016/j.foodchem.2016.11.089 ↗
38. Study the effects of saffron on depression and lipid profiles: A double blind comparative study10.1016/j.ajp.2015.10.012 ↗
39. The effect of saffron on weight and lipid profile: A systematic review, meta-analysis, and dose–response of randomized clinical trials10.1002/ptr.6420 ↗
40. Nichols, M., Townsend, N., Luengo-Fernandez, R., Leal, J., Gray, A., Scarborough, P., and Rayner, M. (2012). European Cardiovascular Disease Statistics, European Heart Network.
41. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation10.1161/CIR.0b013e31820a55f5 ↗
42. Ezzati, M., Lopez, A.D., Rodgers, A., and Murray, C.J.L. (2004). Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, World Health Organization.